article Open AccessTop 1% cited

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

Lara D. Veeken · 2017 · Vol. 57(1) · pp. e1–e45

Caroline Gordon✉(University of Birmingham)Maame-Boatemaa Amissah-Arthur(University of Birmingham)Mary Gayed(University Hospitals Birmingham NHS Foundation Trust)Sue Brown(Royal National Hospital for Rheumatic Diseases)Ian N Bruce(University of Manchester)David D’Cruz(Guy's Hospital)Benjamin EmpsonBridget Griffiths(Freeman Hospital)David Jayne(Addenbrooke's Hospital)Munther A. Khamashta(St Thomas' Hospital)Liz Lightstone(Imperial College London)Peter Norton(LUPUS UK)Yvonne Norton(LUPUS UK)Karen Schreiber(King's College London)David Isenberg(University College London)for the British Society for Rheumatology Standards, Audit and Guidelines Working Group

View via DOI Full-text PDF

Abstract

Background SLE (or lupus for short) is a multisystem, autoimmune disease, involving complex pathogenetic mechanisms that can present at any age. It most commonly presents in women in the reproductive age group, although lupus is increasingly recognized after the age of 40 years, particularly in Europeans Lupus affected nearly 1 in 1000 of the population in the UK in 2012 [4] and was NICE has accredited the process used by the BSR to produce its guidance on the management of systemic lupus erythematosus in adults.

Systemic Lupus Erythematosus Research Lymphoma Diagnosis and Treatment Systemic Sclerosis and Related DiseasesMedicineRheumatologySystemic lupus erythematosusGuidelineLupus erythematosusPopulationImmunologyInternal medicineDiseaseIntensive care medicine